Pros Well-known telehealth brand Easy-to-use platform Multiple healthcare categories Cons Availability varies by location Pricing may differ between programs Best For Patients who prefer established telehealth brands Individuals seeking broader healthcare services 3
Methodology: The study authors conducted an exhaustive search through Medline and the Cochrane Library for RCTs assessing the maintenance doses of subcutaneous tirzepatide at 5, 10, or 15 mg once-weekly, or subcutaneous semaglutide at 0.5, 1.0, or 2.0 mg once-weekly, spanning a minimum of 12 weeks
This evaluation should include assessment of body mass index (BMI) to confirm eligibility (BMI 30, or 27 with at least one weight-related comorbidity such as hypertension, dyslipidemia, type 2 diabetes, or obstructive sleep apnea), previous weight loss attempts, and realistic expectations for treatment outcomes
Each visit allows us to monitor your progress and make any necessary dose adjustments to optimize your results